Shenzhen Salubris Pharmaceuticals Co., Ltd.

SZSE:002294 Stock Report

Market Cap: CN¥29.1b

Shenzhen Salubris Pharmaceuticals Future Growth

Future criteria checks 2/6

Shenzhen Salubris Pharmaceuticals is forecast to grow earnings and revenue by 17.5% and 15.8% per annum respectively. EPS is expected to grow by 17.6% per annum. Return on equity is forecast to be 9.5% in 3 years.

Key information

17.5%

Earnings growth rate

17.6%

EPS growth rate

Pharmaceuticals earnings growth17.9%
Revenue growth rate15.8%
Future return on equity9.5%
Analyst coverage

Low

Last updated20 May 2024

Recent future growth updates

Recent updates

Shenzhen Salubris Pharmaceuticals Co., Ltd.'s (SZSE:002294) Share Price Not Quite Adding Up

May 22
Shenzhen Salubris Pharmaceuticals Co., Ltd.'s (SZSE:002294) Share Price Not Quite Adding Up

A Look At The Fair Value Of Shenzhen Salubris Pharmaceuticals Co., Ltd. (SZSE:002294)

Apr 17
A Look At The Fair Value Of Shenzhen Salubris Pharmaceuticals Co., Ltd. (SZSE:002294)

Is Shenzhen Salubris Pharmaceuticals (SZSE:002294) A Risky Investment?

Feb 28
Is Shenzhen Salubris Pharmaceuticals (SZSE:002294) A Risky Investment?

Earnings and Revenue Growth Forecasts

SZSE:002294 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20265,4869177601,2174
12/31/20254,6847867369424
12/31/20243,9696475791,3933
3/31/20243,569569262944N/A
12/31/20233,365580168839N/A
9/30/20233,390577121806N/A
6/30/20233,498627388916N/A
3/31/20233,434611402931N/A
1/1/20233,482637372971N/A
9/30/20223,4196814811,032N/A
6/30/20223,3506457681,276N/A
3/31/20223,2286167261,231N/A
1/1/20223,0585347021,185N/A
9/30/20212,7921855101,063N/A
6/30/20212,57910140597N/A
3/31/20212,63866341878N/A
12/31/20202,739617321,374N/A
9/30/20203,0412668111,408N/A
6/30/20203,6502791,1711,774N/A
3/31/20204,1485441,0431,680N/A
12/31/20194,4707151,0491,507N/A
9/30/20194,6811,0251,0671,479N/A
6/30/20194,7411,3011,2381,599N/A
3/31/20194,7141,3641,1781,475N/A
12/31/20184,6521,4581,0081,341N/A
9/30/20184,5871,5081,1741,494N/A
6/30/20184,3861,5119401,280N/A
3/31/20184,3081,4919421,336N/A
12/31/20174,1541,452N/A1,458N/A
9/30/20174,1061,451N/A1,406N/A
6/30/20173,9761,432N/A1,507N/A
3/31/20173,8911,415N/A1,557N/A
12/31/20163,8331,396N/A1,435N/A
9/30/20163,7391,380N/A1,503N/A
6/30/20163,7111,341N/A1,340N/A
3/31/20163,6101,310N/A1,170N/A
12/31/20153,4781,266N/A1,056N/A
9/30/20153,4671,217N/A972N/A
6/30/20153,2371,166N/A921N/A
3/31/20153,0151,102N/A978N/A
12/31/20142,8831,042N/A982N/A
9/30/20142,686989N/A877N/A
6/30/20142,570933N/A909N/A
3/31/20142,450883N/A761N/A
12/31/20132,327830N/A669N/A
9/30/20132,108793N/A619N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 002294's forecast earnings growth (17.5% per year) is above the savings rate (2.9%).

Earnings vs Market: 002294's earnings (17.5% per year) are forecast to grow slower than the CN market (22.3% per year).

High Growth Earnings: 002294's earnings are forecast to grow, but not significantly.

Revenue vs Market: 002294's revenue (15.8% per year) is forecast to grow faster than the CN market (13.7% per year).

High Growth Revenue: 002294's revenue (15.8% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 002294's Return on Equity is forecast to be low in 3 years time (9.5%).


Discover growth companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.